Trial Profile

A Phase 2 Clinical Trial of GH001 in Patients With Bipolar II Disorder and a Current Major Depressive Episode

Status: Discontinued

Phase of Trial: Phase II

Latest Information Update: 25 May 2025

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

15 May 2025 According to a GH Research media release, company announces acceptance of poster has been accepted presenting safety and tolerability data at the International Society for Bipolar Disorders (ISBD) Annual Conference in Chiba, Japan from September 17 -19.
08 May 2025 According to a GH Research media release, Data analysis for this trial is ongoing and further clinical trial results are expected to be provided at upcoming scientific conferences.
14 Feb 2025 According to ClinicalTrials.gov: US National Institutes of Health, this trial is Terminated as Recruitment of this patient population was more challenging than anticipated. The sponsor concluded that a sufficient amount of patients have completed the trial to demonstrate proof of concept in this patient population.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com